Jazz Historical Cash Flow
| JAZZ Stock | USD 124.34 2.33 1.84% |
Analysis of Jazz Pharmaceuticals cash flow over time is an excellent tool to project Jazz Pharmaceuticals PLC future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 925.6 M or Depreciation of 670.6 M as it is a great indicator of Jazz Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Jazz Pharmaceuticals PLC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Jazz Pharmaceuticals PLC is a good buy for the upcoming year.
Jazz |
About Jazz Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Jazz balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Jazz's non-liquid assets can be easily converted into cash.
Jazz Pharmaceuticals Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Jazz Pharmaceuticals PLC to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Jazz Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Jazz Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Jazz Pharmaceuticals PLC current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jazz Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At this time, Jazz Pharmaceuticals' Cash And Cash Equivalents Changes is fairly stable compared to the past year. Cash Flows Other Operating is likely to rise to about 876.1 M in 2024, whereas Change To Inventory is likely to drop (14.1 M) in 2024.
Jazz Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Jazz Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Jazz Pharmaceuticals cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (32.8M) | (30.5M) | (48.9M) | (49.6M) | (13.4M) | (14.1M) | |
| Change In Cash | 327.7M | 420.4M | (466.3M) | 290.0M | 624.8M | 656.1M | |
| Free Cash Flow | 594.1M | 520.4M | 733.0M | 773.8M | 1.1B | 1.1B | |
| Change In Working Capital | (150.1M) | (85.4M) | (48.0M) | 9.9M | (204.4M) | (194.2M) | |
| Begin Period Cash Flow | 309.6M | 637.3M | 1.1B | 591.4M | 881.5M | 925.6M | |
| Other Cashflows From Financing Activities | 41.1M | 82.8M | 99.7M | 52.6M | (4.5M) | (4.3M) | |
| Depreciation | 370.2M | 278.3M | 552.5M | 629.5M | 638.7M | 670.6M | |
| Other Non Cash Items | 159.0M | 484.2M | 345.4M | 926.9M | 276.3M | 170.7M | |
| Capital Expenditures | 182.3M | 379.3M | 45.5M | 498.2M | 24.0M | 22.8M | |
| Total Cash From Operating Activities | 776.4M | 899.6M | 778.5M | 1.3B | 1.1B | 1.1B | |
| Net Income | 523.4M | 238.6M | (329.7M) | (224.1M) | 414.8M | 435.6M | |
| Total Cash From Financing Activities | (293.7M) | 528.1M | 4.0B | (529.5M) | (305.3M) | (290.0M) | |
| End Period Cash Flow | 637.3M | 1.1B | 591.4M | 881.5M | 1.5B | 1.6B | |
| Change To Liabilities | (644K) | 64.6M | 54.7M | 141.7M | 162.9M | 171.1M | |
| Other Cashflows From Investing Activities | (1.0B) | (350.0M) | (5.2B) | (416.1M) | (374.5M) | (393.3M) | |
| Sale Purchase Of Stock | (301.5M) | (146.5M) | (35.6M) | (54K) | (269.8M) | (256.3M) | |
| Stock Based Compensation | 110.6M | 121.0M | 189.0M | 222.0M | 226.8M | 238.2M | |
| Total Cashflows From Investing Activities | (155.3M) | (1.0B) | (5.2B) | (446.2M) | (401.6M) | (421.7M) | |
| Change To Account Receivables | (92.3M) | (38.6M) | (92.7M) | (90.1M) | (51.9M) | (54.5M) | |
| Investments | (155.3M) | (642.7M) | 1.1B | (1.0M) | (589.2M) | (559.8M) | |
| Net Borrowings | (33.4M) | 591.8M | 3.9B | (582.0M) | (669.3M) | (635.9M) | |
| Change To Netincome | (9.3M) | 155.2M | 603.6M | 139.1M | 160.0M | 90.9M | |
| Change To Operating Activities | (38.5M) | (5.6M) | 54.5M | 164.7M | 189.4M | 198.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Jazz Stock Analysis
When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.